FFA
VNDA icon

Farther Finance Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

Farther Finance Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.2K Buy
2,979
+671
+29% +$4.38K ﹤0.01% 4041
2026
Q1 		$16.3K Buy
2,308
+366
+19% +$2.82K ﹤0.01% 3791
2025
Q4 		$17.1K Sell
1,942
-18
-0.9% -$99 ﹤0.01% 3540
2025
Q3 		$9.78K Buy
1,960
+300
+18% +$1.39K ﹤0.01% 3456
2025
Q2 		$7.83K Buy
1,660
+1,435
+638% +$6.28K ﹤0.01% 3198
2025
Q1 		$1.01K Sell
225
-303
-57% -$1.41K ﹤0.01% 3611
2024
Q4 		$2.53K Hold
528
– – ﹤0.01% 2913
2024
Q3 		$2.48K Buy
528
+48
+10% +$257 ﹤0.01% 2917
2024
Q2 		$2.68K Buy
480
+287
+149% +$1.48K ﹤0.01% 2671
2024
Q1 		$795 Sell
193
-262
-58% -$1.05K ﹤0.01% 2861
2023
Q4 		$1.92K Buy
455
+297
+188% +$1.2K ﹤0.01% 2445
2023
Q3 		$683 Sell
158
-23
-13% -$128 ﹤0.01% 2183
2023
Q2 		$1.19K Buy
181
+23
+15% +$147 ﹤0.01% 1915
2023
Q1 		$1.07K Sell
158
-48
-23% -$337 ﹤0.01% 1826
2022
Q4 		$1.52K Buy
+206
New +$2.01K ﹤0.01% 1539

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Farther Finance Advisors's VNDA Position: Q2 2026 in Review

Farther Finance Advisors increased its Vanda Pharmaceuticals (VNDA) stake by 29% in Q2 2026, buying an estimated $4.38K and bringing the position to 2,979 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4041.

Farther Finance Advisors first reported a position in VNDA in Q4 2022 and has held it in 15 quarters since. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Farther Finance Advisors held 2,979 shares of Vanda Pharmaceuticals worth $18.2K as of Q2 2026.
  • Farther Finance Advisors bought 671 Vanda Pharmaceuticals shares in Q2 2026, an estimated $4.38K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4041 holding.
  • Farther Finance Advisors first reported a position in Vanda Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.